Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (031L0161C)
Article History
First Online: 4 February 2020
Compliance with Ethical Standards
:
: The project has received support from the project “Open-source modeling framework for automated quality control and management of complex life science systems models” (OSMOSES), which is funded by the German Federal Ministry of Education and Research (BMBF, Grant ID 031L0161C).
: Bernd Meibohm has provided consulting services to Boehringer Ingelheim, the maker of dabigatran and idarucizumab, on unrelated development projects. Laura Maria Fuhr, Nina Hanke, and Thorsten Lehr have no conflicts of interest that are directly relevant to the content of this article.